Quest Diagnostics Inc. logo

Quest Diagnostics Inc. (DGX)

Market Closed
17 Jul, 20:00
NYSE NYSE
$
210. 68
+1.27
+0.6065%
$
22.34B Market Cap
20.12 P/E Ratio
5.98% Div Yield
955,500 Volume
8.71 Eps
$ 209.41
Previous Close
Add Transaction
Day Range
209.41 214.4
Year Range
165.19 219.2
Want to track DGX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Is This the Right Time to Hold DGX Stock in Your Portfolio?

Is This the Right Time to Hold DGX Stock in Your Portfolio?

Quest Diagnostics gains from DIS growth, advanced diagnostics uptake and AI-driven efficiencies, though debt levels and healthcare reimbursement risks remain concerns.

Zacks | 2 months ago
Bullish Quarterly Results: 3 Companies Raising Guidance

Bullish Quarterly Results: 3 Companies Raising Guidance

Guidance upgrades are generally among the most bullish announcements a company can make, signaling that the outlook is even better than previously expected.

Zacks | 2 months ago
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term

Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 months ago
Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock

Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 months ago
These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Earnings

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Earnings

Quest Diagnostics Incorporated (NYSE:DGX) on Tuesday reported upbeat earnings for the first quarter on Tuesday.

Benzinga | 2 months ago
Is Quest Diagnostics Inc (DGX) Overvalued After 4.5% Rally? GF Value Says Overvalued

Is Quest Diagnostics Inc (DGX) Overvalued After 4.5% Rally? GF Value Says Overvalued

On April 21, 2026, Quest Diagnostics Inc (DGX) shares rose 4.5% to a current price of $205.04. This move is part of a broader uptrend, with the stock experienci

Gurufocus | 2 months ago
Quest Diagnostics Incorporated (DGX) Q1 2026 Earnings Call Transcript

Quest Diagnostics Incorporated (DGX) Q1 2026 Earnings Call Transcript

Quest Diagnostics Incorporated (DGX) Q1 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy?

Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 3 months ago
Here's How Quest Diagnostics Is Placed Ahead of Q1 Earnings

Here's How Quest Diagnostics Is Placed Ahead of Q1 Earnings

DGX heads into Q1 earnings with steady growth expectations, but estimate cuts and a negative ESP could temper the outlook.

Zacks | 3 months ago
Quest Diagnostics (DGX) Reports Next Week: Wall Street Expects Earnings Growth

Quest Diagnostics (DGX) Reports Next Week: Wall Street Expects Earnings Growth

Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 3 months ago
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock

Here's Why Quest Diagnostics (DGX) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 3 months ago
Quest Diagnostics Incorporated $DGX Stock Position Increased by 8 Knots Management LLC

Quest Diagnostics Incorporated $DGX Stock Position Increased by 8 Knots Management LLC

8 Knots Management LLC grew its position in Quest Diagnostics Incorporated (NYSE: DGX) by 56.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 275,344 shares of the medical research company's stock after purchasing an additional 98,806 shares during the period. Quest Diagnostics makes

Defenseworld | 4 months ago
Loading...
Load More